trending Market Intelligence /marketintelligence/en/news-insights/trending/aSNkEcfPowymLnXPooQWfA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Bio-Path Holdings to raise $18.5M for working capital

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Bio-Path Holdings to raise $18.5M for working capital

Bio-Path Holdings Inc. plans to raise about $18.5 million in a registered direct offering to several institutional investors.

The Bellaire, Texas-based biotechnology company, which develops cancer medicines, will offer 712,910 common shares at $25.95 apiece.

Proceeds from the offering will be used for working capital and general corporate purposes.

Bio-Path expects to close the offering on or about March 14, subject to closing conditions.

H.C. Wainwright & Co. is the exclusive placement agent for the offering.